197 related articles for article (PubMed ID: 24645630)
21. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata.
Dovigo LN; Pavarina AC; Mima EG; Giampaolo ET; Vergani CE; Bagnato VS
Mycoses; 2011 Mar; 54(2):123-30. PubMed ID: 19889173
[TBL] [Abstract][Full Text] [Related]
22. Relative Abundances of Candida albicans and Candida glabrata in
Olson ML; Jayaraman A; Kao KC
Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29427422
[No Abstract] [Full Text] [Related]
23. In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms.
Kawai A; Yamagishi Y; Mikamo H
J Infect Chemother; 2015 Sep; 21(9):647-53. PubMed ID: 26141813
[TBL] [Abstract][Full Text] [Related]
24. [Molecular mechanisms of fluconazole resistance in clinical isolates of Candida glabrata].
Shen YZ; Lu HZ; Zhang YX
Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):245-9. PubMed ID: 20450660
[TBL] [Abstract][Full Text] [Related]
25. Flucytosine antagonism of azole activity versus Candida glabrata: role of transcription factor Pdr1 and multidrug transporter Cdr1.
Steier Z; Vermitsky JP; Toner G; Gygax SE; Edlind T; Katiyar S
Antimicrob Agents Chemother; 2013 Nov; 57(11):5543-7. PubMed ID: 23979762
[TBL] [Abstract][Full Text] [Related]
26. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.
Sanglard D; Ischer F; Bille J
Antimicrob Agents Chemother; 2001 Apr; 45(4):1174-83. PubMed ID: 11257032
[TBL] [Abstract][Full Text] [Related]
27. Doxorubicin selects for fluconazole-resistant petite mutants in Candida glabrata isolates.
Schulz B; Knobloch M; Weber K; Ruhnke M
Int J Med Microbiol; 2012 Jul; 302(3):155-61. PubMed ID: 22664377
[TBL] [Abstract][Full Text] [Related]
28. The Candida glabrata putative sterol transporter gene CgAUS1 protects cells against azoles in the presence of serum.
Nakayama H; Tanabe K; Bard M; Hodgson W; Wu S; Takemori D; Aoyama T; Kumaraswami NS; Metzler L; Takano Y; Chibana H; Niimi M
J Antimicrob Chemother; 2007 Dec; 60(6):1264-72. PubMed ID: 17913716
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory activity of hinokitiol against biofilm formation in fluconazole-resistant Candida species.
Kim DJ; Lee MW; Choi JS; Lee SG; Park JY; Kim SW
PLoS One; 2017; 12(2):e0171244. PubMed ID: 28152096
[TBL] [Abstract][Full Text] [Related]
30. Bioactivity and cellular structure of Candida albicans and Candida glabrata biofilms grown in the presence of fluconazole.
Gomes PN; da Silva WJ; Pousa CC; Narvaes EA; Del Bel Cury AA
Arch Oral Biol; 2011 Nov; 56(11):1274-81. PubMed ID: 21549350
[TBL] [Abstract][Full Text] [Related]
31. Nonidentical function of Upc2A binding sites in the Candida glabrata CDR1 promoter.
Vu BG; Moye-Rowley WS
Genetics; 2022 Sep; 222(2):. PubMed ID: 36063046
[TBL] [Abstract][Full Text] [Related]
32. The multidrug resistance transporters CgTpo1_1 and CgTpo1_2 play a role in virulence and biofilm formation in the human pathogen Candida glabrata.
Santos R; Costa C; Mil-Homens D; Romão D; de Carvalho CC; Pais P; Mira NP; Fialho AM; Teixeira MC
Cell Microbiol; 2017 May; 19(5):. PubMed ID: 27780306
[TBL] [Abstract][Full Text] [Related]
33. Mutation of the CgPDR16 gene attenuates azole tolerance and biofilm production in pathogenic Candida glabrata.
Culakova H; Dzugasova V; Perzelova J; Gbelska Y; Subik J
Yeast; 2013 Oct; 30(10):403-14. PubMed ID: 23939632
[TBL] [Abstract][Full Text] [Related]
34. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.
Borst A; Raimer MT; Warnock DW; Morrison CJ; Arthington-Skaggs BA
Antimicrob Agents Chemother; 2005 Feb; 49(2):783-7. PubMed ID: 15673768
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility of Candida glabrata biofilms to echinocandins: alterations in the matrix composition.
Rodrigues CF; Rodrigues ME; Henriques M
Biofouling; 2018 May; 34(5):569-578. PubMed ID: 29798695
[TBL] [Abstract][Full Text] [Related]
36. Serum cholesterol promotes the growth of Candida glabrata in the presence of fluconazole.
Nagi M; Tanabe K; Nakayama H; Yamagoe S; Umeyama T; Oura T; Ohno H; Kajiwara S; Miyazaki Y
J Infect Chemother; 2013 Feb; 19(1):138-43. PubMed ID: 23233084
[TBL] [Abstract][Full Text] [Related]
37. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic.
Silva S; Pires P; Monteiro DR; Negri M; Gorup LF; Camargo ER; Barbosa DB; Oliveira R; Williams DW; Henriques M; Azeredo J
Med Mycol; 2013 Feb; 51(2):178-84. PubMed ID: 22803822
[TBL] [Abstract][Full Text] [Related]
38. Silver colloidal nanoparticles: antifungal effect against adhered cells and biofilms of Candida albicans and Candida glabrata.
Monteiro DR; Gorup LF; Silva S; Negri M; de Camargo ER; Oliveira R; Barbosa DB; Henriques M
Biofouling; 2011 Aug; 27(7):711-9. PubMed ID: 21756192
[TBL] [Abstract][Full Text] [Related]
39. Local silencing controls the oxidative stress response and the multidrug resistance in Candida glabrata.
Orta-Zavalza E; Guerrero-Serrano G; Gutiérrez-Escobedo G; Cañas-Villamar I; Juárez-Cepeda J; Castaño I; De Las Peñas A
Mol Microbiol; 2013 Jun; 88(6):1135-48. PubMed ID: 23651300
[TBL] [Abstract][Full Text] [Related]
40. Adhesive and biofilm-forming Candida glabrata Lebanese hospital isolates harbour mutations in subtelomeric silencers and adhesins.
Fattouh N; Husni R; Finianos M; Bitar I; Khalaf RA
Mycoses; 2024 Jun; 67(6):e13750. PubMed ID: 38813959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
